Please login to the form below

Not currently logged in

EMA starts review of Xtandi in non-metastatic prostate cancer

astellas headquartersThe evaluation is based on positive results from the PROSPER trial

IQVIA partners with Box

IQVIAWill work on managing content for the life science industry

NICE says OK to Keytruda for bladder cancer via the CDF

merck-keytruda-pembrolizumab-melanomaBecomes the first immunotherapy recommended for UC after chemotherapy

FDA approves another home genetic testing service

23andme genetic research23andMe’s kit will check for an increased risk of certain cancers developing

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Bayer looks to leverage AI across the pharma value chain

Dieter Weinand outlines his hopes for applying artificial intelligence

Bayer symbol

Lighthouse bolsters its US senior scientific team

Marc Pondel joins the agency as executive medical science director


Digital mania - a question of value

In the scramble to implement digital solutions, are we forgetting some of the basics?

Anthony Rowbottom

HAVAS SO appoints director of SO Creative

James March will lead the SO Creative advertising team

James March

Investing in digital could 'unlock £22bn' for UK pharma

Accenture outlines tech's revenue-growth and cost-saving potential

Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?